Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025296 <b>Size:</b> 672 KB

New Form N-PX - BlackRock ESG Capital Allocation Term Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002405 <b>Size:</b> 1 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025295 <b>Size:</b> 701 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001214659-26-011026 <b>Size:</b> 78 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001214659-26-011025 <b>Size:</b> 78 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025294 <b>Size:</b> 534 KB

New Form N-PX - BlackRock Technology & Private Equity Term Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002404 <b>Size:</b> 424 KB

New Form N-PX - BlackRock Capital Allocation Term Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002403 <b>Size:</b> 2 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025293 <b>Size:</b> 977 KB

General Announcement: Changes in Subsidiary for the Second Quarter of 2026

(99% Neutral) LABCORP HOLDINGS INC. (LH) Files Form 8-K

Novavaxs Partnership Strategy Continues to Deliver with XFG-adaptedNuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

New Form N-PX - BlackRock Health Sciences Term Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002402 <b>Size:</b> 1 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025292 <b>Size:</b> 977 KB

New Form N-PX - BlackRock Science & Technology Term Trust <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002401 <b>Size:</b> 422 KB